TNF blockers control psoriatic arthritis

San Francisco - Both tumor necrosis factor (TNF) blockers etanercept and infliximab continue to play an emerging role in the treatment of psoriatic arthritis (PsA), according to two new studies presented at the American College of Rheumatology annual meeting here.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.